東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Essays on technological change in he...

Williams, Heidi Lie.

Linked to FindBook

Google Book

Amazon

博客來

Essays on technological change in health care markets.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Essays on technological change in health care markets./
Author:	Williams, Heidi Lie.
Description:	172 p.
Notes:	Source: Dissertation Abstracts International, Volume: 71-07, Section: A, page: 2573.
Contained By:	Dissertation Abstracts International71-07A.
Subject:	Economics, General. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3415432
ISBN:	9781124091129

Essays on technological change in health care markets.
Williams, Heidi Lie.

Essays on technological change in health care markets. - 172 p.

Source: Dissertation Abstracts International, Volume: 71-07, Section: A, page: 2573.

Thesis (Ph.D.)--Harvard University, 2010.

This dissertation consists of three essays studying the causes and consequences of technological change in health care markets. The first and third essays shed light on factors affecting the rate and direction of technological change in health care markets, and the second essay contributes a methodology for measuring the impacts of technological change on health care costs and health outcomes.

ISBN: 9781124091129Subjects--Topical Terms:

1017424
Economics, General.

Essays on technological change in health care markets.
LDR:03127nam 2200313 4500 001 1395095
005 20110506125606.5
008 130515s2010 ||||||||||||||||| ||eng d
020 $a 9781124091129
035 $a (UMI)AAI3415432
035 $a AAI3415432
040 $a UMI $c UMI
100 1 $a Williams, Heidi Lie. $3 1673752
245 1 0 $a Essays on technological change in health care markets.
300 $a 172 p.
500 $a Source: Dissertation Abstracts International, Volume: 71-07, Section: A, page: 2573.
500 $a Adviser: Lawrence Katz.
502 $a Thesis (Ph.D.)--Harvard University, 2010.
520 $a This dissertation consists of three essays studying the causes and consequences of technological change in health care markets. The first and third essays shed light on factors affecting the rate and direction of technological change in health care markets, and the second essay contributes a methodology for measuring the impacts of technological change on health care costs and health outcomes.
520 $a The first essay provides empirical evidence on how intellectual property (IP) on a given technology affects subsequent innovation. To shed light on this question, I analyze the sequencing of the human genome by the public Human Genome Project and the private firm Celera, and estimate the impact of Celera's gene-level IP on subsequent scientific research and product development outcomes. The analyses suggest Celera's IP led to reductions in subsequent scientific research and product development outcomes on the order of 30 percent.
520 $a The second essay (co-authored with Doug Almond, Joe Doyle, and Amanda Kowalski) proposes a research design to estimate the marginal returns to medical spending. Specifically, we use a regression discontinuity design to compare health outcomes and medical treatment provision for newborns on either side of the "very low birth weight" threshold at 1500 grams. Assuming that observed medical spending fully captures the impact of the "very low birth weight" designation on mortality, our estimates suggest that the cost of saving a statistical life of a newborn with birth weight near 1500 grams is on the order of $5 50,000 in 2006 dollars.
520 $a The third essay analyzes whether changes in the availability of complementary technologies can induce changes in market size, and in turn impact incentives for innovation. I analyze the introduction of the prostate-specific antigen (PSA) test, a screening test for prostate cancer that dramatically increased the number of men diagnosed as "having" prostate cancer, relative to the previously used screening test. In a difference-in-difference framework, I find evidence that the introduction of the PSA test led to a positive and statistically significant increase in innovation on treatments for prostate cancer, relative to other types of cancer.
590 $a School code: 0084.
650 4 $a Economics, General. $3 1017424
650 4 $a Health Sciences, General. $3 1017817
690 $a 0501
690 $a 0566
710 2 $a Harvard University. $3 528741
773 0 $t Dissertation Abstracts International $g 71-07A.
790 1 0 $a Katz, Lawrence, $e advisor
790 $a 0084
791 $a Ph.D.
792 $a 2010
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3415432